Article, Early Access, 2024

Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity

DIABETES THERAPY, ISSN 1869-6953, 10.1007/s13300-024-01562-1

Contributors

Klein, Klara R. (Corresponding author) [1] [2] [3] Abrahamsen, Trine J. [4] Kahkoska, Anna R. [1] [2] [3] Alexander, G. Caleb [5] [6] [7] Chute, Christopher G. [5] Haendel, Melissa [8] [9] Hong, Stephanie S. [5] [6] Mehta, Hemalkumar [5] [7] Moffitt, Richard [10] [11] Sturmer, Til [1] [2] [3] Kvist, Kajsa [4] Buse, John B. [1] [2] [3]

Affiliations

  1. [1] Univ N Carolina, Dept Med, Div Endocrinol & Metab, Sch Med, Campus Box 7172,8072 Burnett Womack,160 Dent Circl, Chapel Hill, NC 27599 USA
    2. [NORA names: United States; America, North; OECD];
  2. [2] Univ N Carolina, Dept Med, Div Endocrinol & Metab, Sch Med, Campus Box 7172,8072 Burnett Womack,160 Dent Circl, Chapel Hill, NC 27599 USA
    3. [NORA names: United States; America, North; OECD];
  3. [3] Univ N Carolina, Dept Med, Div Endocrinol & Metab, Sch Med, Campus Box 7172,8072 Burnett Womack,160 Dent Circl, Chapel Hill, NC 27599 USA
    4. [NORA names: United States; America, North; OECD];
  4. [4] Novo Nordisk AS, Soborg, Denmark
    5. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD];
  5. [5] Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
    6. [NORA names: United States; America, North; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

COVID-19, GLP-1RA, National COVID Cohort Collaborative (N3C), Observational data, SARS-CoV-2, SGLT-2i, Type 2 diabetes

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+